North Dakota
How Amgen Inc. v. Connecticut Retirement Plans and Trust Funds applies in North Dakota: state-specific rules, key cases, and bar exam notes for Civil Procedure.
North Dakota law adopts a similar standard to the one established in Amgen. The state recognizes the importance of establishing the materiality of information in securities fraud cases and mirrors the federal criteria regarding the pleading standards required to advance claims.
Under North Dakota Rule of Civil Procedure 9(b), fraud must be pleaded with particularity, which aligns with the materiality standard set forth in the Amgen decision.
The court emphasized the need for specificity in alleging fraud and the material impact of misrepresentations.
Included the requirement of materiality in disclosing evidence related to allegations of impropriety.
Held that litigants must demonstrate how omitted information affected shareholder decisions to establish material misrepresentation.
North Dakota's approach aligns closely with federal standards as articulated in the Amgen case, particularly regarding the materiality of information in pleading requirements. Both jurisdictions require a clear demonstration that the alleged misrepresentations could influence a reasonable investor's decision-making process.
Understanding the principles from Amgen is crucial for the North Dakota bar exam, especially in sections covering civil procedure and securities regulation.